Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatric Neurosurgery · Aqueductal Stenosis

How Common Is Aqueductal Stenosis? Incidence Rates

At a Glance

Congenital aqueductal stenosis is rare, affecting an estimated 1 to 4 in 10,000 births. It accounts for about 20% to 45% of congenital hydrocephalus cases, but study methods vary and these figures cannot predict one person’s symptoms or treatment.

Aqueductal stenosis is a rare condition. The aqueduct of Sylvius is a narrow channel that carries cerebrospinal fluid (CSF) between spaces in the brain called ventricles. When this channel narrows or becomes blocked (stenosis), fluid builds up, leading to obstructive hydrocephalus.

While exact numbers vary depending on how and where data is collected, medical research estimates that congenital (present at birth) aqueductal stenosis occurs in approximately 1 to 4 out of every 10,000 births [1][2]. If you have recently been diagnosed, it is completely normal to feel isolated. However, pediatric neurosurgeons and hydrocephalus specialists have extensive experience managing this condition.

Key Takeaways on Incidence

  • Congenital aqueductal stenosis is uncommon, estimated at 1 to 4 per 10,000 births [1][2].
  • It is one of the recognized common causes of pediatric hydrocephalus [3][4].
  • Birth statistics do not capture all adult-onset cases or cases acquired later in life.
  • Statistics describe large groups and cannot predict your individual symptoms, treatment needs, or prognosis.

How Aqueductal Stenosis Fits Into Hydrocephalus

Aqueductal stenosis is widely recognized as one of the common causes of congenital hydrocephalus [3][4]. Hydrocephalus itself occurs at different rates globally. For instance, research estimates about 68 per 100,000 births (or 0.68 per 1,000) in the United States and Canada, compared to 145 per 100,000 in Africa and 316 per 100,000 in Latin America [5].

When looking specifically at children diagnosed with congenital hydrocephalus, aqueductal stenosis is attributed to 20% to 45% of cases in various studies [6][7][8]. However, this range heavily depends on the specific hospital, referral patterns, and diagnostic criteria. For example, a specialized surgical center only evaluating patients selected for specific procedures will report different percentages than a general pediatric hospital [8][9].

Genetic Factors and L1CAM

A specific genetic form of this condition involves variants in the L1CAM gene, which provides instructions for a protein that helps brain cells connect. Because this gene is located on the X chromosome, this condition (often called L1 syndrome or X-linked hydrocephalus) primarily affects males, though females can occasionally experience symptoms as carriers. X-linked hydrocephalus is estimated to occur in about 1 in 30,000 male births [10][11].

Among males with non-syndromic congenital hydrocephalus (meaning hydrocephalus is the only major medical issue), L1CAM variants are thought to explain about 5% to 10% of cases [12].

Many cases of aqueductal stenosis appear to be sporadic, meaning there is no known family history. However, having no family history does not rule out a genetic cause. New genetic mutations (de novo variants) can occur, or a recessively inherited condition could be present. Decisions about genetic testing are best made with your care team or a genetic counselor.

Congenital vs. Acquired Stenosis

It can be difficult to pinpoint a single overall prevalence rate for aqueductal stenosis because the condition takes different forms:

  • Definitions: Some studies only count isolated cases (where the narrowing is the only medical issue), while others include complex cases involving other genetic syndromes or brain anomalies [13].
  • Acquired vs. Congenital: While many people are born with the condition (congenital), the aqueduct can also become blocked later in life (acquired) due to infections, bleeding, or tumors. The rates of acquired cases fluctuate depending on local rates of infection and access to medical care [14][15]. Limited access to care primarily changes how often the condition is detected and reported, rather than changing the biological rate of the disease itself.
  • Adult Presentations: Sometimes, a congenital narrowing remains undiagnosed for decades and only causes symptoms in adulthood. Therefore, an adult diagnosis does not automatically mean the obstruction was acquired later in life. Current birth statistics do not fully capture how common these adult presentations are.

Ultimately, these statistics help researchers understand population trends, but they do not define your journey. Treatment choices—such as a shunt (a tube that drains fluid) or an ETV (endoscopic third ventriculostomy, a procedure that creates a bypass pathway)—will depend on your individual anatomy, age, and symptoms, not on global statistics.

Common questions in this guide

How often is congenital aqueductal stenosis diagnosed?
Congenital aqueductal stenosis is estimated to occur in about 1 to 4 out of every 10,000 births. The exact figure varies because studies use different definitions and data sources.
How much of congenital hydrocephalus is linked to aqueductal stenosis?
Studies attribute about 20% to 45% of congenital hydrocephalus cases to aqueductal stenosis. This range can differ by hospital, referral patterns, and diagnostic criteria, so it is not a universal rate.
Is aqueductal stenosis more common in boys?
The L1CAM-related form, called X-linked hydrocephalus or L1 syndrome, primarily affects males because the gene is on the X chromosome. It is estimated at about 1 in 30,000 male births, but this does not describe all aqueductal stenosis.
Can aqueductal stenosis first be found in adulthood?
Yes. A narrowing present from birth may remain undiagnosed for years, while an acquired blockage can develop later because of infection, bleeding, or a tumor. Therefore, an adult diagnosis does not by itself show when the narrowing began.
Does a lack of family history rule out a genetic cause?
No. Some cases result from a new gene change or a recessively inherited condition, so there may be no known family history. A clinician or genetic counselor can help determine whether genetic testing is appropriate.
Does the incidence rate determine whether someone needs a shunt or ETV?
No. Treatment depends on individual factors such as anatomy, age, symptoms, and the cause of the obstruction. Clinicians may consider a shunt or endoscopic third ventriculostomy, which creates a new pathway for cerebrospinal fluid.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How did my MRI or CT scan show aqueductal obstruction, and do you think mine is congenital, acquired, or uncertain?
  2. 2.Is my or my child's aqueductal stenosis considered isolated, or is it associated with other genetic or structural conditions?
  3. 3.Are there genetic tests you recommend, and would meeting with a genetic counselor be helpful even if we have no family history?
  4. 4.How does the specific cause of the stenosis influence treatment options, such as choosing between a shunt or an ETV?
  5. 5.What specific symptoms, such as rapidly worsening headache, repeated vomiting, or confusion, should prompt us to seek urgent care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    North American Fetal Therapy Network: Maternal Outcomes in Fetal Aqueductal Stenosis.

    Emery SP, Lopa S, Peterson E, et al.

    Fetal diagnosis and therapy 2024; (51(6)):612-616 doi:10.1159/000540196.

    PMID: 38981455
  2. 2

    In vitro and in vivo assessment of a novel ultra-flexible ventriculoamniotic shunt for treating fetal hydrocephalus.

    Emery SP, Greene S, Elsisy M, et al.

    Journal of biomaterials applications 2023; (37(8)):1423-1435 doi:10.1177/08853282221125309.

    PMID: 36063383
  3. 3

    Hydrocephalus in children.

    Kahle KT, Kulkarni AV, Limbrick DD, Warf BC

    Lancet (London, England) 2016; (387(10020)):788-99.

    PMID: 26256071
  4. 4

    Diagnosis and Surgical Management of Neonatal Hydrocephalus.

    Pindrik J, Schulz L, Drapeau A

    Seminars in pediatric neurology 2022; (42()):100969 doi:10.1016/j.spen.2022.100969.

    PMID: 35868728
  5. 5

    Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis.

    Dewan MC, Rattani A, Mekary R, et al.

    Journal of neurosurgery 2019; (130(4)):1065-1079 doi:10.3171/2017.10.JNS17439.

    PMID: 29701543
  6. 6

    Clinical analysis of aqueductal stenosis in patients with hydrocephalus in a Kenyan setting.

    Kaur LP, Munyiri NJ, Dismus WV

    The Pan African medical journal 2017; (26()):106 doi:10.11604/pamj.2017.26.106.11050.

    PMID: 28533829
  7. 7

    Programmable Versus Differential Pressure Ventriculoperitoneal Shunts for Pediatric Hydrocephalus: A 20-Year Single-Center Experience From Saudi Arabia.

    Alomar SA, Saiedi RJ, Albukhari SM, et al.

    Cureus 2023; (15(8)):e43369 doi:10.7759/cureus.43369.

    PMID: 37700950
  8. 8

    The Role of Early Postoperative Intracranial Pressure Monitoring in Predicting the Outcome of Endoscopic Third Ventriculostomy Performed in Infants With Congenital Hydrocephalus: A Prospective Analysis.

    Yadav A, Verma R

    Cureus 2022; (14(2)):e22354 doi:10.7759/cureus.22354.

    PMID: 35371677
  9. 9

    Endoscopic third ventriculostomy and choroid plexus cauterization with a rigid neuroendoscope in infants with hydrocephalus.

    Weil AG, Fallah A, Chamiraju P, et al.

    Journal of neurosurgery. Pediatrics 2016; (17(2)):163-173 doi:10.3171/2015.5.PEDS14692.

    PMID: 26517057
  10. 10

    A Novel Silent Mutation in the L1CAM Gene Causing Fetal Hydrocephalus Detected by Whole-Exome Sequencing.

    Sun Y, Li Y, Chen M, et al.

    Frontiers in genetics 2019; (10()):817 doi:10.3389/fgene.2019.00817.

    PMID: 31572438
  11. 11

    Effects of L1 adhesion molecule agonistic mimetics on signal transduction in neuronal functions.

    Nagaraj V, Kim R, Martianou T, et al.

    Biochemical and biophysical research communications 2023; (642()):27-34 doi:10.1016/j.bbrc.2022.12.031.

    PMID: 36543021
  12. 12

    Surprisingly good outcome in antenatal diagnosis of severe hydrocephalus related to CCDC88C deficiency.

    Wallis M, Baumer A, Smaili W, et al.

    European journal of medical genetics 2018; (61(4)):189-196 doi:10.1016/j.ejmg.2017.12.002.

    PMID: 29225145
  13. 13

    Short- and Long-Term Outcomes of Prenatally Identified Congenital Aqueductal Stenosis by Fetal MRI.

    Smith NJ, Nagaraj UD, Kline-Fath BM, et al.

    Prenatal diagnosis 2024; (44(13)):1574-1584 doi:10.1002/pd.6690.

    PMID: 39434200
  14. 14

    Hydrocephalus due to multiple ependymal malformations is caused by mutations in the MPDZ gene.

    Saugier-Veber P, Marguet F, Lecoquierre F, et al.

    Acta neuropathologica communications 2017; (5(1)):36 doi:10.1186/s40478-017-0438-4.

    PMID: 28460636
  15. 15

    Maternal and infant factors associated with infancy-onset hydrocephalus in Washington State.

    Tully HM, Capote RT, Saltzman BS

    Pediatric neurology 2015; (52(3)):320-5.

    PMID: 25542767

This page is for informational purposes only and does not constitute medical advice. A neurosurgeon, hydrocephalus specialist, or genetic counselor can explain how the incidence data relates to your or your child’s situation.

Get notified when new evidence is published on Hydrocephalus with stenosis of the aqueduct of Sylvius.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.